Final Four
| Competitor Name | Times Picked |
| CD-19 CAR-T | 12 |
| BiTEs | 12 |
| TYK2 in SLE | 8 |
| SGCAPS | 7 |
| Pred dose in SLE | 7 |
| Oral anti-IL-23 | 5 |
| Anifrolumab extension | 4 |
| Obinutuzumab in LN | 4 |
| HCQ Screen Cost | 3 |
| CD40L in Sjogren's | 3 |
| ABA in Pre-RA | 2 |
| STRAP Trial | 1 |
Championship Match
| Competitor Name | Times Picked |
| BiTEs | 12 |
| CD-19 CAR-T | 11 |
| Obinutuzumab in LN | 3 |
| CD40L in Sjogren's | 3 |
| Oral anti-IL-23 | 1 |
| SGCAPS | 1 |
| Anifrolumab extension | 1 |
| HCQ Screen Cost | 1 |
| Pred dose in SLE | 1 |
Champion
| Competitor Name | Times Picked |
| CD-19 CAR-T | 7 |
| BiTEs | 6 |
| CD40L in Sjogren's | 1 |
| SGCAPS | 1 |
| Anifrolumab extension | 1 |
| Obinutuzumab in LN | 1 |
|